• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用有序逻辑回归分析确定中国 COVID-19 疾病严重程度的决定因素。

Application of ordinal logistic regression analysis to identify the determinants of illness severity of COVID-19 in China.

机构信息

Department of Respiration and Critical Care Diseases, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Institute of Respiratory Diseases, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

出版信息

Epidemiol Infect. 2020 Jul 7;148:e146. doi: 10.1017/S0950268820001533.

DOI:10.1017/S0950268820001533
PMID:32631458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7369341/
Abstract

Corona Virus Disease 2019 (COVID-19) has presented an unprecedented challenge to the health-care system across the world. The current study aims to identify the determinants of illness severity of COVID-19 based on ordinal responses. A retrospective cohort of COVID-19 patients from four hospitals in three provinces in China was established, and 598 patients were included from 1 January to 8 March 2020, and divided into moderate, severe and critical illness group. Relative variables were retrieved from electronic medical records. The univariate and multivariate ordinal logistic regression models were fitted to identify the independent predictors of illness severity. The cohort included 400 (66.89%) moderate cases, 85 (14.21%) severe and 113 (18.90%) critical cases, of whom 79 died during hospitalisation as of 28 April. Patients in the age group of 70+ years (OR = 3.419, 95% CI: 1.596-7.323), age of 40-69 years (OR = 1.586, 95% CI: 0.824-3.053), hypertension (OR = 3.372, 95% CI: 2.185-5.202), ALT >50 μ/l (OR = 3.304, 95% CI: 2.107-5.180), cTnI >0.04 ng/ml (OR = 7.464, 95% CI: 4.292-12.980), myohaemoglobin>48.8 ng/ml (OR = 2.214, 95% CI: 1.42-3.453) had greater risk of developing worse severity of illness. The interval between illness onset and diagnosis (OR = 1.056, 95% CI: 1.012-1.101) and interval between illness onset and admission (OR = 1.048, 95% CI: 1.009-1.087) were independent significant predictors of illness severity. Patients of critical illness suffered from inferior survival, as compared with patients in the severe group (HR = 14.309, 95% CI: 5.585-36.659) and in the moderate group (HR = 41.021, 95% CI: 17.588-95.678). Our findings highlight that the identified determinants may help to predict the risk of developing more severe illness among COVID-19 patients and contribute to optimising arrangement of health resources.

摘要

新型冠状病毒病 2019(COVID-19)对全球医疗体系提出了前所未有的挑战。本研究旨在基于有序反应识别 COVID-19 疾病严重程度的决定因素。建立了来自中国三个省的四家医院的 COVID-19 患者回顾性队列,纳入了 2020 年 1 月 1 日至 3 月 8 日的 598 例患者,并分为中度、重度和危重症组。从电子病历中检索相对变量。拟合单变量和多变量有序逻辑回归模型,以确定疾病严重程度的独立预测因素。该队列包括 400 例(66.89%)中度病例、85 例(14.21%)重度病例和 113 例(18.90%)危重症病例,截至 4 月 28 日,其中 79 人在住院期间死亡。70 岁以上年龄组患者(OR=3.419,95%CI:1.596-7.323)、40-69 岁年龄组患者(OR=1.586,95%CI:0.824-3.053)、高血压患者(OR=3.372,95%CI:2.185-5.202)、ALT>50μ/l(OR=3.304,95%CI:2.107-5.180)、cTnI>0.04ng/ml(OR=7.464,95%CI:4.292-12.980)、肌红蛋白>48.8ng/ml(OR=2.214,95%CI:1.42-3.453)患者发生更严重疾病的风险更高。发病与诊断之间的间隔(OR=1.056,95%CI:1.012-1.101)和发病与入院之间的间隔(OR=1.048,95%CI:1.009-1.087)是疾病严重程度的独立显著预测因素。危重症患者的生存预后差于重症组(HR=14.309,95%CI:5.585-36.659)和中度组(HR=41.021,95%CI:17.588-95.678)。我们的研究结果表明,确定的决定因素可能有助于预测 COVID-19 患者发生更严重疾病的风险,并有助于优化卫生资源的配置。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dec/7369341/5aee39e0205d/S0950268820001533_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dec/7369341/5aee39e0205d/S0950268820001533_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dec/7369341/5aee39e0205d/S0950268820001533_fig1.jpg

相似文献

1
Application of ordinal logistic regression analysis to identify the determinants of illness severity of COVID-19 in China.应用有序逻辑回归分析确定中国 COVID-19 疾病严重程度的决定因素。
Epidemiol Infect. 2020 Jul 7;148:e146. doi: 10.1017/S0950268820001533.
2
Clinical characteristics of different subtypes and risk factors for the severity of illness in patients with COVID-19 in Zhejiang, China.中国浙江 COVID-19 患者不同亚型的临床特征及疾病严重程度的危险因素。
Infect Dis Poverty. 2020 Jul 8;9(1):85. doi: 10.1186/s40249-020-00710-6.
3
Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.中国江苏省重症 COVID-19 患者的临床特征和危险因素:一项回顾性多中心队列研究。
BMC Infect Dis. 2020 Aug 6;20(1):584. doi: 10.1186/s12879-020-05314-x.
4
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
5
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.中国 COVID-19 不良临床结局的危险因素:一项多中心、回顾性、观察性研究。
Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020.
6
Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.苏格兰 COVID-19 合并症和治疗的快速流行病学分析(REACT-SCOT):一项基于人群的病例对照研究。
PLoS Med. 2020 Oct 20;17(10):e1003374. doi: 10.1371/journal.pmed.1003374. eCollection 2020 Oct.
7
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.新型冠状病毒肺炎合并多发性硬化患者的临床特征和结局。
JAMA Neurol. 2020 Sep 1;77(9):1079-1088. doi: 10.1001/jamaneurol.2020.2581.
8
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
9
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
10
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.中国儿童 SARS-CoV-2 感染的临床和流行病学特征:一项多中心病例系列研究。
PLoS Med. 2020 Jun 16;17(6):e1003130. doi: 10.1371/journal.pmed.1003130. eCollection 2020 Jun.

引用本文的文献

1
The effects of cognitive leisure activities on frailty transitions in older adults in China: a CHARLS-Based longitudinal study.基于 CHARLS 数据的中国老年人认知休闲活动对衰弱转变的影响:一项纵向研究。
BMC Public Health. 2024 May 27;24(1):1405. doi: 10.1186/s12889-024-18889-w.
2
Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic.高血压与 SARS-CoV-2 感染患者的死亡率:大流行 2 年后的观察性研究的荟萃分析。
Eur J Intern Med. 2023 Feb;108:28-36. doi: 10.1016/j.ejim.2022.11.018. Epub 2022 Nov 17.
3
Association of polymorphisms in long pentraxin 3 and its plasma levels with COVID-19 severity.

本文引用的文献

1
Erratum to: Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of Evidence.《高血压、肾素-血管紧张素系统与下呼吸道感染及肺损伤风险:对2019冠状病毒病的影响:欧洲高血压学会2019冠状病毒病特别工作组证据综述》勘误
Cardiovasc Res. 2021 Sep 28;117(11):2394. doi: 10.1093/cvr/cvab224.
2
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
3
长五聚素 3 多态性及其血浆水平与 COVID-19 严重程度的关联。
Clin Exp Med. 2023 Aug;23(4):1225-1233. doi: 10.1007/s10238-022-00926-w. Epub 2022 Oct 31.
4
Decline of onset-to-diagnosis interval and its impacts on clinical outcome of COVID-19 in China: a nation-wide observational study.中国 COVID-19 的发病至诊断间隔时间下降及其对临床结局的影响:一项全国性观察研究。
BMC Infect Dis. 2022 Aug 5;22(1):674. doi: 10.1186/s12879-022-07660-4.
5
Using logistic regression to develop a diagnostic model for COVID-19: A single-center study.使用逻辑回归建立COVID-19诊断模型:一项单中心研究。
J Educ Health Promot. 2022 Jun 11;11:153. doi: 10.4103/jehp.jehp_1017_21. eCollection 2022.
6
Clinical Characteristics, Risk Factors for Severity and Pharmacotherapy in Hospitalized COVID-19 Patients in the United Arab Emirates.阿拉伯联合酋长国住院COVID-19患者的临床特征、严重程度危险因素及药物治疗
J Clin Med. 2022 Apr 26;11(9):2439. doi: 10.3390/jcm11092439.
7
A look back at the first wave of COVID-19 in China: A systematic review and meta-analysis of mortality and health care resource use among severe or critical patients.回顾中国的 COVID-19 第一波疫情:严重或危重症患者的死亡率和医疗资源利用的系统评价和荟萃分析。
PLoS One. 2022 Mar 11;17(3):e0265117. doi: 10.1371/journal.pone.0265117. eCollection 2022.
8
Spatial-temporal generalized additive model for modeling COVID-19 mortality risk in Toronto, Canada.用于模拟加拿大多伦多新冠病毒疾病(COVID-19)死亡风险的时空广义相加模型
Spat Stat. 2022 Jun;49:100526. doi: 10.1016/j.spasta.2021.100526. Epub 2021 Jul 6.
9
Fatality and risk features for prognosis in COVID-19 according to the care approach - a retrospective cohort study.根据治疗方法评估 COVID-19 预后的病死率和风险特征:一项回顾性队列研究。
PLoS One. 2021 Mar 23;16(3):e0248869. doi: 10.1371/journal.pone.0248869. eCollection 2021.
10
Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19.COVID-19 严重程度和死亡率预测因素的心脏标志物的荟萃分析。
Int J Infect Dis. 2021 Apr;105:551-559. doi: 10.1016/j.ijid.2021.03.008. Epub 2021 Mar 9.
Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies.
肝损伤与2019年冠状病毒病(COVID-19)重症感染相关:一项回顾性研究的系统评价和荟萃分析
Hepatol Res. 2020 Aug;50(8):924-935. doi: 10.1111/hepr.13510. Epub 2020 Jun 25.
4
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.中国江苏省 2019 年冠状病毒病患者的临床特征:一项回顾性、多中心研究。
PLoS Negl Trop Dis. 2020 May 8;14(5):e0008280. doi: 10.1371/journal.pntd.0008280. eCollection 2020 May.
5
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.意大利北部因 COVID-19 和心脏病住院患者的特征和结局。
Eur Heart J. 2020 May 14;41(19):1821-1829. doi: 10.1093/eurheartj/ehaa388.
6
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.中国 COVID-19 患者肝损伤标志物与死亡率的纵向关联。
Hepatology. 2020 Aug;72(2):389-398. doi: 10.1002/hep.31301.
7
COVID-19 with Different Severities: A Multicenter Study of Clinical Features.不同严重程度的 COVID-19:一项多中心临床特征研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. doi: 10.1164/rccm.202002-0445OC.
8
Clinical utility of cardiac troponin measurement in COVID-19 infection.新型冠状病毒感染患者中心肌肌钙蛋白检测的临床效用。
Ann Clin Biochem. 2020 May;57(3):202-205. doi: 10.1177/0004563220921888. Epub 2020 Apr 27.
9
Cardiovascular disease and COVID-19.心血管疾病与新型冠状病毒肺炎
Diabetes Metab Syndr. 2020 May-Jun;14(3):247-250. doi: 10.1016/j.dsx.2020.03.013. Epub 2020 Mar 25.
10
Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.COVID-19 患者的肝损伤:来自中国武汉市单个中心的 115 例回顾性分析。
Liver Int. 2020 Sep;40(9):2095-2103. doi: 10.1111/liv.14455. Epub 2020 Apr 28.